Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3526

Actual shortage: 229 (6%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3283 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (13%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-22 159722
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-11-07 159725
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-20 2023-02-09 175312
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-27 2023-01-06 175895
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-13 2023-04-21 181107
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-16 2023-05-12 185019
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-04-27 185927
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-06 2023-06-09 191880
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-23 196297
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-10-20 203804
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-04-19 209298
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-26 214241
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-02-23 217300
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-02 2024-02-23 218376
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-01 2024-03-22 221096
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-08 2024-03-15 221717

Showing 1941 to 1960 of 3526

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959

Showing 161 to 180 of 366